Mounjaro®
Starting from £179.99/mo
Start journey Learn moreStomach gurgling is one of the more surprising things people notice after starting tirzepatide. Mounjaro slows the speed at which food moves through your digestive system, and that change in gut motility is the direct cause of the rumbling many people hear in the first weeks of treatment. It is common, it is not a sign that something has gone wrong, and for most people it settles. These are prescription-only medicines assessed and issued by a GPhC-registered prescriber; if your symptoms feel severe or persistent, that conversation should happen with your clinical team.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Tirzepatide activates both GIP and GLP-1 receptors, two pathways involved in regulating appetite and digestive speed. Slowing gastric emptying is an intended pharmacological effect: food stays in the stomach longer, signals of fullness arrive sooner, and overall calorie intake falls. The SURMOUNT-1 trial, published in the New England Journal of Medicine, documented gastrointestinal symptoms as the most commonly reported side-effect class across thousands of participants. Nausea, diarrhoea, constipation, and bloating all featured, and the mechanism behind each of them is closely related to that same shift in gut transit time.
Belly rumbling sits in the same family, and if you want a closer look at why this happens on tirzepatide specifically, our guide to Mounjaro stomach rumbling explains the bowel mechanics in plain terms. When the bowel is processing contents more slowly, gas and liquid continue to move through sections that are not yet ready to pass them along. The resulting sounds (borborygmi, in clinical language) are the bowel doing exactly what it should, just at a pace the gut hasn't adapted to yet. This is not a sign of intolerance or a reason to stop treatment without speaking to your prescriber first. For background on what tirzepatide is doing inside your body, the full tirzepatide guide covers the mechanism in more detail.
Most people notice the rumbling most acutely in two windows: the first two weeks after starting the 2.5 mg pen, and again in the days following each dose increase. Treatment begins at 2.5 mg to allow the gut to adjust gradually before the prescriber steps the dose upward. The NHS patient information for tirzepatide confirms that gastrointestinal effects are most common during the start of treatment and after dose changes, and that they typically ease as the body acclimates.
A quick habit worth building: spend thirty seconds before each meal rating your hunger on a simple scale of one to ten. People on tirzepatide often misjudge portion size in the early weeks because appetite signals arrive differently, eating past comfortable fullness is a reliable trigger for both bloating and gurgling. Tracking this takes no equipment and often reveals a pattern within a week. More on managing abdominal discomfort specifically can be found on the Mounjaro belly ache page, which covers the distinction between normal gut adjustment and symptoms that warrant a call to your prescriber.
If the rumbling started specifically at the 5 mg or higher stage, that is almost certainly the dose-adjustment effect rather than a new problem. It does not mean the medicine is wrong for you.
The NHS guidance on tirzepatide side effects recommends several straightforward dietary measures to reduce GI symptoms broadly, and these apply directly to rumbling too. Eating more slowly (putting cutlery down between bites is a genuinely effective rather than a decorative tip) gives a stomach that empties more slowly the time it needs. Smaller, more frequent meals reduce the volume the gut has to hold at any one point. Carbonated drinks introduce gas into a system that is already managing gas less efficiently, so cutting them out for the first weeks of each new dose is worth trying.
Foods that ferment rapidly in the gut, such as certain legumes, raw brassicas, and high-fructose items, can amplify the sound without adding meaningful nutritional value at this stage of treatment. Prioritising protein and cooked vegetables keeps gut load manageable. Staying well hydrated matters too: the constipation that sometimes accompanies slowed transit makes gurgling louder. Aiming for roughly 1.5 to 2 litres of plain water through the day is a reasonable baseline, though your prescriber may adjust that if you have other conditions.
People who are also curious about how tirzepatide affects fat distribution specifically will find the Mounjaro and belly fat page useful, the gut changes described here are separate from, though related to, the metabolic effects that drive visceral fat loss over the longer course of treatment.
Rumbling alone, without accompanying pain, is nearly always a self-resolving adjustment symptom. The picture changes if you also notice severe or persistent abdominal pain, pain that radiates toward your back, vomiting that prevents you from keeping fluids down, or signs of dehydration such as dark urine and dizziness. In January 2026 the MHRA issued a Drug Safety Update highlighting acute pancreatitis as a known, though infrequent, serious effect of GLP-1 medicines; severe stomach pain that reaches through to the back is the key symptom to act on promptly. Report any suspected side effects through the MHRA Yellow Card scheme, and contact a healthcare professional the same day if that pattern appears.
Gurgling that has been present since the start of treatment and is slowly improving is almost certainly the dose-adjustment process at work. If it is getting worse at a stable dose after several weeks, or if it is accompanied by significant cramping, that warrants a clinical review rather than a wait-and-see approach. Our prescribers are available seven days a week to discuss exactly this kind of question. If you have not yet started treatment and want to understand what to expect, the Mounjaro treatment page sets out the full clinical picture, and the free consultation is the starting point for anyone considering it through a registered UK pharmacy. Information on what Mounjaro costs privately is available if you want the cost context before you begin.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.